Please make a donation to the Aplastic Anemia and MDS International Foundation.
Donate Today
Background: Allogeneic haematopoietic stem-cell transplant is an option, potentially curative, for high-risk acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) patients.
Background: Sabatolimab Sabatolimab: Sabatolimab (MBG453) is a novel immuno-myeloid therapy that binds to TIM-3 on immune cells, facilitating antileukemic immune activation and phagocytic
Background: The DNA methyltransferase inhibitors azacitidine azacitidine: It works by reducing the amount of methylation in the body.
Background: Unmet medical needs remain in patients with red blood cell transfusion red blood cell transfusion: A pro
Escape from immune surveillance is a hallmark of cancer.
Risk stratification and prognostication are crucial for the appropriate management of patients with myelodysplastic syndromes myelodysplastic syn
